109 related articles for article (PubMed ID: 19290526)
21. The duplicitous nature of the Lyn tyrosine kinase in growth factor signaling.
Hibbs ML; Harder KW
Growth Factors; 2006 Jun; 24(2):137-49. PubMed ID: 16801133
[TBL] [Abstract][Full Text] [Related]
22. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
23. WT1 protein expression in childhood acute leukemia.
Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I
Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786
[TBL] [Abstract][Full Text] [Related]
24. RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.
Side LE; Curtiss NP; Teel K; Kratz C; Wang PW; Larson RA; Le Beau MM; Shannon KM
Genes Chromosomes Cancer; 2004 Mar; 39(3):217-23. PubMed ID: 14732923
[TBL] [Abstract][Full Text] [Related]
25. Cytokines and microRNA in pediatric B-acute lymphoblastic leukemia.
Cocco C; Airoldi I
Cytokine Growth Factor Rev; 2011 Jun; 22(3):149-56. PubMed ID: 21764355
[TBL] [Abstract][Full Text] [Related]
26. 14q32/miRNA clusters loss of heterozygosity in acute lymphoblastic leukemia is associated with up-regulation of BCL11a.
Agueli C; Cammarata G; Salemi D; Dagnino L; Nicoletti R; La Rosa M; Messana F; Marfia A; Bica MG; Coniglio ML; Pagano M; Fabbiano F; Santoro A
Am J Hematol; 2010 Aug; 85(8):575-8. PubMed ID: 20578197
[TBL] [Abstract][Full Text] [Related]
27. Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia.
Hidaka H; Yagasaki H; Takahashi Y; Hama A; Nishio N; Tanaka M; Yoshida N; Villalobos IB; Wang Y; Xu Y; Horibe K; Chen S; Kadomatsu K; Kojima S
Leuk Res; 2007 Aug; 31(8):1045-51. PubMed ID: 17267033
[TBL] [Abstract][Full Text] [Related]
28. DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia.
Shiba N; Taki T; Park MJ; Shimada A; Sotomatsu M; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Arakawa H; Hayashi Y
Br J Haematol; 2012 Feb; 156(3):413-4. PubMed ID: 21981547
[No Abstract] [Full Text] [Related]
29. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.
Melki JR; Vincent PC; Clark SJ
Cancer Res; 1999 Aug; 59(15):3730-40. PubMed ID: 10446989
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of p16INK4A and p14ARF in haematological malignancies.
Lee YK; Park JY; Kang HJ; Cho HC
Clin Lab Haematol; 2003 Aug; 25(4):233-7. PubMed ID: 12890162
[TBL] [Abstract][Full Text] [Related]
31. Association of Janus kinase 2 (JAK2) polymorphisms with acute leukemia susceptibility.
Zhong Y; Wu J; Ma R; Cao H; Wang Z; Ding J; Cheng L; Feng J; Chen B
Int J Lab Hematol; 2012 Jun; 34(3):248-53. PubMed ID: 22168550
[TBL] [Abstract][Full Text] [Related]
32. LYN Kinase in the Tumor Microenvironment Is Essential for the Progression of Chronic Lymphocytic Leukemia.
Nguyen PH; Fedorchenko O; Rosen N; Koch M; Barthel R; Winarski T; Florin A; Wunderlich FT; Reinart N; Hallek M
Cancer Cell; 2016 Oct; 30(4):610-622. PubMed ID: 27728807
[TBL] [Abstract][Full Text] [Related]
33. Functions of the Lyn tyrosine kinase in health and disease.
Ingley E
Cell Commun Signal; 2012 Jul; 10(1):21. PubMed ID: 22805580
[TBL] [Abstract][Full Text] [Related]
34. HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen.
Frezzato F; Gattazzo C; Martini V; Trimarco V; Teramo A; Carraro S; Cabrelle A; Ave E; Facco M; Zambello R; Tibaldi E; Brunati AM; Semenzato G; Trentin L
PLoS One; 2012; 7(6):e39902. PubMed ID: 22768161
[TBL] [Abstract][Full Text] [Related]
35. Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion.
Yano M; Imamura T; Asai D; Kiyokawa N; Nakabayashi K; Matsumoto K; Deguchi T; Hashii Y; Honda YK; Hasegawa D; Sasahara Y; Ishii M; Kosaka Y; Kato K; Shima M; Hori H; Yumura-Yagi K; Hara J; Oda M; Horibe K; Ichikawa H; Sato A
Br J Haematol; 2015 Dec; 171(5):813-7. PubMed ID: 26404892
[TBL] [Abstract][Full Text] [Related]
36. LYN kinase programs stromal fibroblasts to facilitate leukemic survival via regulation of c-JUN and THBS1.
Vom Stein AF; Rebollido-Rios R; Lukas A; Koch M; von Lom A; Reinartz S; Bachurski D; Rose F; Bozek K; Abdallah AT; Kohlhas V; Saggau J; Zölzer R; Zhao Y; Bruns C; Bröckelmann PJ; Lohneis P; Büttner R; Häupl B; Oellerich T; Nguyen PH; Hallek M
Nat Commun; 2023 Mar; 14(1):1330. PubMed ID: 36899005
[TBL] [Abstract][Full Text] [Related]
37. Comparison of gene-expression profiles in parallel bone marrow and peripheral blood samples in acute myeloid leukaemia by real-time polymerase chain reaction.
Sakhinia E; Farahangpour M; Tholouli E; Liu Yin JA; Hoyland JA; Byers RJ
J Clin Pathol; 2006 Oct; 59(10):1059-65. PubMed ID: 16644881
[TBL] [Abstract][Full Text] [Related]
38. Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With
Dai HP; Yin J; Li Z; Yang CX; Cao T; Chen P; Zong YH; Zhu MQ; Zhu XM; Xiao S; Wu DP; Tang XW
Front Oncol; 2020; 10():359. PubMed ID: 32266142
[No Abstract] [Full Text] [Related]
39. Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia.
Zonta F; Pagano MA; Trentin L; Tibaldi E; Frezzato F; Gattazzo C; Martini V; Trimarco V; Mazzorana M; Bordin L; Semenzato G; Brunati AM
Blood; 2014 Feb; 123(6):875-83. PubMed ID: 24352878
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA dysregulation and multi-targeted therapy for cancer treatment.
Balatti V; Croce CM
Adv Biol Regul; 2020 Jan; 75():100669. PubMed ID: 31640928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
